Literature DB >> 7087966

Properdin is a trimer.

R G Discipio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7087966     DOI： 10.1016/0161-5890(82)90232-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN： 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  8 in total

1.  Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

2.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 3.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys.

Authors:  T Melvin; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

Review 5.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Properdin and factor h: opposing players on the alternative complement pathway "see-saw".

Authors:  Lubna Kouser; Munirah Abdul-Aziz; Annapurna Nayak; Cordula M Stover; Robert B Sim; Uday Kishore
Journal:  Front Immunol       Date:  2013-04-23       Impact factor: 7.561

7.  Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.

Authors:  S Meri; V Koistinen; A Miettinen; T Törnroth; I J Seppälä
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

8.  Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement Activation.

Authors:  Lubna Kouser; Basudev Paudyal; Anuvinder Kaur; Gudrun Stenbeck; Lucy A Jones; Suhair M Abozaid; Cordula M Stover; Emmanuel Flahaut; Robert B Sim; Uday Kishore
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.